Kingsview Wealth Management LLC Invests $10.29 Million in Cigna Group $CI

Kingsview Wealth Management LLC acquired a new stake in Cigna Group (NYSE:CI) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 37,331 shares of the health services provider’s stock, valued at approximately $10,291,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Wilkerson Advisory Group LLC acquired a new position in Cigna Group in the fourth quarter valued at approximately $25,000. Osbon Capital Management LLC acquired a new stake in Cigna Group during the second quarter worth approximately $26,000. Cedar Mountain Advisors LLC raised its holdings in Cigna Group by 161.9% during the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after purchasing an additional 68 shares in the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Cigna Group during the 2nd quarter worth approximately $29,000. Finally, Fiduciary Financial Advisors purchased a new stake in shares of Cigna Group during the 2nd quarter worth approximately $29,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Up 0.4%

Shares of NYSE:CI opened at $278.89 on Friday. The stock has a market cap of $73.69 billion, a P/E ratio of 11.54, a P/E/G ratio of 0.96 and a beta of 0.29. The firm has a fifty day moving average price of $283.52 and a 200 day moving average price of $281.39. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. The company had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. Cigna Group’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period last year, the firm posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Sell-side analysts predict that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Insider Transactions at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the sale, the insider directly owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. This represents a 41.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 23,012 shares of company stock worth $6,386,550. Corporate insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

CI has been the topic of a number of recent analyst reports. Morgan Stanley increased their target price on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research report on Wednesday, May 20th. Jefferies Financial Group cut shares of Cigna Group from a “buy” rating to a “hold” rating and reduced their price target for the company from $336.00 to $307.00 in a research report on Tuesday, August 4th. Cantor Fitzgerald upped their price objective on shares of Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research note on Friday, May 1st. Barclays raised their price objective on Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Finally, Sanford C. Bernstein lifted their target price on Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a research report on Thursday, July 9th. Fifteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cigna Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $339.45.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.